Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Gastrin/cholecystokinin type B receptor | ||
Ligand | BDBM50045801 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEBML_49880 | ||
Ki | 224±n/a nM | ||
Citation | Blommaert, AG; Weng, JH; Dorville, A; McCort, I; Ducos, B; Durieux, C; Roques, BP Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties. J Med Chem36:2868-77 (1993) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
Gastrin/cholecystokinin type B receptor | |||
Name: | Gastrin/cholecystokinin type B receptor | ||
Synonyms: | CCK-2 receptor | CCK-B receptor | CCK-BR | CCKBR | CCKRB | Cholecystokinin A | Cholecystokinin receptor | Cholecystokinin-2 Receptor | GASR_HUMAN | Gastrin/cholecystokinin type B receptor | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 48445.79 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Stable expression of human CCK-2 receptors in HEK 293 cells. | ||
Residue: | 447 | ||
Sequence: |
| ||
BDBM50045801 | |||
n/a | |||
Name | BDBM50045801 | ||
Synonyms: | CHEMBL95461 | {[2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-propionyl]-phenethyl-amino}-acetic acid | ||
Type | Small organic molecule | ||
Emp. Form. | C32H37N3O5 | ||
Mol. Mass. | 543.6533 | ||
SMILES | OC(=O)CN(CCc1ccccc1)C(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2 |wU:37.39,wD:35.38,33.42,31.44,TLB:29:30:32:35.39.34,THB:38:33:30.37.36:39,36:37:32:35.39.34,36:35:30.37.38:32,(10.53,-4,;9.76,-2.67,;10.53,-1.33,;8.22,-2.67,;7.45,-1.34,;8.22,,;9.76,,;10.53,1.35,;12.07,1.33,;12.84,2.66,;12.06,4.01,;10.51,4.01,;9.75,2.66,;5.91,-1.34,;5.9,-2.88,;4.58,-.57,;3.25,-1.35,;3.27,-2.89,;4.18,-4.13,;3.27,-5.39,;1.8,-4.92,;.45,-5.69,;-.88,-4.92,;-.88,-3.38,;.45,-2.6,;1.8,-3.37,;3.09,-.17,;1.75,.6,;.65,-.47,;1.35,2.09,;-.13,2.49,;-1.46,3.29,;-2.03,4.71,;-3.68,4.55,;-4.78,3.5,;-4.22,2.09,;-2.96,1.45,;-1.88,2.49,;-2.44,3.78,;-2.61,2.19,)| | ||
Structure |